Ha habido 50 transacciones internas recientes registradas para Beam Therapeutics Inc. (BEAM), incluyendo 20 compras y 29 ventas. El total de compras internas fue valorado en $18.2M y el total de ventas internas en $5.62M.
Internos destacados con actividad reciente incluyen Walsh Kathleen E, Evans John M., Ciaramella Giuseppe. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — BEAM
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2033-06-06 |
Walsh Kathleen E |
Director |
Concesión de RSU |
16,532 |
$34.33 |
$567.54K |
16,532 |
| 2026-04-01 |
Evans John M. |
CEO |
Venta Informativa |
30,078 |
$24.58 |
$739.32K |
1,047,205 |
| 2026-04-01 |
Ciaramella Giuseppe |
President |
Venta Informativa |
11,810 |
$24.58 |
$290.29K |
218,406 |
| 2026-04-01 |
Bellon Christine |
Chief Legal Officer |
Venta Informativa |
5,956 |
$24.58 |
$146.4K |
109,711 |
| 2026-04-01 |
Simon Amy |
Chief Medical Officer |
Venta Informativa |
6,700 |
$24.58 |
$164.69K |
102,735 |
| 2026-04-01 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Venta Informativa |
3,242 |
$24.58 |
$79.69K |
51,171 |
| 2026-03-31 |
Evans John M. |
CEO |
Ejercicio de Opciones (Venta) |
25,000 |
$0.67 |
$16.75K |
18,672 |
| 2026-03-31 |
Ciaramella Giuseppe |
President |
Concesión de RSU |
40,000 |
- |
- |
230,216 |
| 2026-03-31 |
Emany Sravan Kumar |
Chief Financial Officer |
Concesión de RSU |
31,750 |
- |
- |
105,456 |
| 2026-03-31 |
Bellon Christine |
Chief Legal Officer |
Concesión de RSU |
20,000 |
- |
- |
115,667 |
| 2026-03-31 |
Simon Amy |
Chief Medical Officer |
Concesión de RSU |
31,750 |
- |
- |
109,114 |
| 2026-03-31 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Concesión de RSU |
20,000 |
- |
- |
54,813 |
| 2026-03-30 |
Evans John M. |
CEO |
Ejercicio de Opciones (Venta) |
25,000 |
$0.67 |
$16.75K |
43,672 |
| 2026-02-24 |
Ciaramella Giuseppe |
President |
Venta Informativa |
35,000 |
$32.00 |
$1.12M |
190,216 |
| 2026-01-31 |
Evans John M. |
CEO |
Concesión de RSU |
180,000 |
$27.62 |
$4.97M |
180,000 |
| 2026-01-31 |
Ciaramella Giuseppe |
President |
Concesión de RSU |
80,000 |
$27.62 |
$2.21M |
80,000 |
| 2026-01-31 |
Emany Sravan Kumar |
Chief Financial Officer |
Concesión de RSU |
63,500 |
$27.62 |
$1.75M |
63,500 |
| 2026-01-31 |
Bellon Christine |
Chief Legal Officer |
Concesión de RSU |
40,000 |
$27.62 |
$1.1M |
40,000 |
| 2026-01-31 |
Simon Amy |
Chief Medical Officer |
Concesión de RSU |
88,500 |
$27.62 |
$2.44M |
88,500 |
| 2026-01-31 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Concesión de RSU |
40,000 |
$27.62 |
$1.1M |
40,000 |
| 2026-01-30 |
Evans John M. |
CEO |
Ejercicio de Opciones (Venta) |
25,000 |
$0.67 |
$16.75K |
68,672 |
| 2026-01-29 |
Evans John M. |
CEO |
Ejercicio de Opciones (Venta) |
19,336 |
$0.67 |
$12.96K |
- |
| 2026-01-22 |
Bellon Christine |
Chief Legal Officer |
Venta Informativa |
1,371 |
$34.00 |
$46.61K |
95,667 |
| 2026-01-22 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Venta Informativa |
6,198 |
$35.00 |
$216.93K |
34,813 |
| 2026-01-20 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Venta Informativa |
3,034 |
$30.12 |
$91.38K |
41,011 |
| 2026-01-15 |
Bellon Christine |
Chief Legal Officer |
Venta Informativa |
559 |
$35.40 |
$19.79K |
97,038 |
| 2025-12-31 |
Emany Sravan Kumar |
Chief Financial Officer |
Venta Informativa |
6,294 |
$27.10 |
$170.57K |
73,706 |
| 2025-12-31 |
Bellon Christine |
Chief Legal Officer |
Venta Informativa |
1,254 |
$27.10 |
$33.98K |
115,667 |
| 2025-12-31 |
Simon Amy |
Chief Medical Officer |
Concesión de RSU |
12,500 |
- |
- |
77,364 |
| 2025-10-27 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Venta Informativa |
459 |
$26.68 |
$12.25K |
14 |
| 2025-10-06 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Donación (Otorgada) |
1,232,434 |
- |
- |
841,231 |
| 2025-10-02 |
Evans John M. |
CEO |
Ejercicio de Opciones (Venta) |
25,000 |
$0.67 |
$16.75K |
19,336 |
| 2025-10-01 |
Evans John M. |
CEO |
Ejercicio de Opciones (Venta) |
25,000 |
$0.67 |
$16.75K |
44,336 |
| 2025-10-01 |
Bellon Christine |
Chief Legal Officer |
Venta Informativa |
373 |
$24.53 |
$9.15K |
116,921 |
| 2025-10-01 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Venta Informativa |
467 |
$24.53 |
$11.46K |
44,045 |
| 2025-07-30 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Venta Informativa |
48,374 |
$20.50 |
$991.67K |
2,073,665 |
| 2025-07-03 |
Simon Amy |
Chief Medical Officer |
Venta Informativa |
876 |
$20.12 |
$17.63K |
64,864 |
| 2025-07-01 |
Simon Amy |
Chief Medical Officer |
Venta Informativa |
374 |
$16.94 |
$6.34K |
65,740 |
| 2025-06-04 |
Maraganore John |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Cooper Graham K |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Walsh Kathleen E |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Shaw Christi |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Guindo Chirfi |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Ho Carole |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Fishman Mark |
Director |
Concesión de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-04-02 |
Simon Amy |
Chief Medical Officer |
Venta Informativa |
20,997 |
$17.73 |
$372.29K |
65,742 |
| 2025-04-01 |
Evans John M. |
CEO |
Venta Informativa |
30,663 |
$18.35 |
$562.68K |
986,249 |
| 2025-04-01 |
Ciaramella Giuseppe |
President |
Venta Informativa |
7,434 |
$18.35 |
$136.42K |
190,216 |
| 2025-04-01 |
Bellon Christine |
Chief Legal Officer |
Venta Informativa |
5,674 |
$18.35 |
$104.12K |
117,294 |
| 2025-04-01 |
Simon Amy |
Chief Medical Officer |
Venta Informativa |
9,566 |
$18.35 |
$175.54K |
86,739 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
